MRK
Merck & Co., Inc.F2515-min delayed · EOD close148.36 −0.78% downas of 2026-11-02mkt cap $366B
Pharmaceutical Preparations · SIC 2834 · CIK 0000310158
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $66.6B | 2026-06-30 | 10-Q · 0000310158-26-000212 |
| Revenue (prior year) | $64.2B | 2024-12-31 | 10-K · 0001628280-25-007732 |
| Net income | $3.2B | 2026-06-30 | 10-Q · 0000310158-26-000212 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $130B | 2026-06-30 | 10-Q · 0000310158-26-000212 |
| Current assets | $36.7B | 2026-06-30 | 10-Q · 0000310158-26-000212 |
| Current liabilities | $27.7B | 2026-06-30 | 10-Q · 0000310158-26-000212 |
| Shareholders' equity | $41.9B | 2026-06-30 | 10-Q · 0000310158-26-000212 |